STD Diagnostics Market: Industry Analysis And Forecast(2023-2029)

STD Diagnostics Market Overview

 

Sexually transmitted diseases are generally developed by sexual contact. The bacteria, viruses, or parasites that cause sexually transmitted diseases transfer from person to person in blood, semen, or vaginal and other bodily fluids. These infections are also transmitted nonsexually, such as from mothers to their infants during pregnancy or childbirth, or through blood transfusions or common needles.

 

Increase in awareness among people, and patient education are the other pivotal factors that fuel the growth of the STD Diagnostics Market. An increase in the prevalence of STDs globally, an increase in patient awareness through education campaigns, and a surge in government initiatives are anticipated to drive the STD Diagnostics Market growth. STDs has witnessed substantial growth in their prevalence and incidents in the past decade. With the increase in prevalence, respective countries across the world are focusing on the implementation of national screening programs to expand the coverage of STD diagnosis. Reimbursement policies has also been favorable for STD services. These factors are significantly driving the growth of the global STD Diagnostics Market. The STD Diagnostics Market is segmented on the basis of disease type, location of testing, and region. By disease type, the STD Diagnostics Market is categorized into chlamydia, gonorrhea, herpes simplex virus, syphilis, human papillomavirus, and other diseases, chancroid, and trichomoniasis. By location of testing, the market is bifurcated into laboratory testing, and point-of-care testing.

 

The COVID-19 pandemic reports of sexually transmitted infections decreased due to disruptions to health care and sexually transmitted infections testing services, reports the CDC. Reduced access to testing and diagnoses may have led some people to unwittingly spread infection. Infections rates are again on the increase.  Due to limited intensive care resources, efforts focused primarily on protecting access to critical care services. Preventive services were reduced, and many non-urgent visits were significantly delayed or changed to virtual platforms to preserve personal protective equipment supply and limit patients’ and clinical staff’s exposure risks. All-time high cases of chlamydia and gonorrhea were reported in 2020 in the United States, and more than half of these occur among people aged 16-25, but after the pandemic sexually transmitted infections testing cases has been decreased. 

 

 

 

 

 

 

STD Diagnostics Market Dynamics

The increasing occurrence of sexually transmitted diseases due to unprotected sexual intercourse and drug abuse is one of the key factors driving the STD Diagnostics Market growth. STD diagnostics are generally used to detect various STD-causing agents, such as bacteria, viruses, and parasites, with high accuracy and reliability that aids healthcare providers in defining suitable treatment, preventing disease transmission from mothers to infants, and improving clinical outcomes for patients. The increasing consciousness among people regarding early detection and diagnosis of STDs, which prevent long-term problems, such as infertility, congenital disabilities, cancer, blindness, bone deformities, brain damage, and mental retardation, is acting as another growth-increasing factor.

 

The implementation of various government initiatives to raise awareness regarding sexual health and STD testing and remove the social stigma associated with it through educational campaigns, seminars, and social media advertisements are providing an impetus to STD Diagnostics Market growth. The introduction of at-home STD testing kits that are cost-effective, safe, accurate, and convenient, provide faster results, and maintain privacy is positively influencing the STD Diagnostics Market growth. The recent development of artificial intelligence-based mobile applications that can diagnose STDs by analyzing digital images of an individual’s private parts, thus improving access to STD screenings, maintaining confidentiality, and protecting personal data, is favoring the market growth. Other factors, including significant growth in the healthcare industry, easy availability of STD diagnostics kits across e-commerce platforms, and increasing investment in the research and development of novel diagnostic technologies, are anticipated to drive STD Diagnostics Market growth.

 

STD Diagnostics Market Segment Analysis

 

Based on the Type, The chlamydia segment dominates STD Diagnostics Market in the year 2022 and is expected to do the same during the forecast period. The event monitor has the largest market share in 2022. Chlamydia is an obligate intracellular parasite that functions as a Large virus. Chlamydias are entirely dependent on the host cells for energy metabolism, like viruses. They are true bacteria and differ from viruses in many ways. Like bacteria, chlamydia also possesses both DNA and RNA. It increases STD Diagnostics Market during the forecast period. They multiply by binary fission, whereas viruses go through lytic and lysogenic phases in their life cycle. They also possess ribosomes, which are absent in viruses. Chlamydiae generally exist as nonmotile coccoids. Chlamydia is a genus comprising three typical species 

 

 

 

 

 

 

Based on the Location, The Laboratory segment dominates STD Diagnostics Market in the year 2022 and is expected to do the same during the forecast period. The event monitor has the largest market share in 2022. Laboratory methods are highly significant and reliable. Laboratory tests can identify the cause and detect coinfections you might also has Blood tests. Blood tests confirm the diagnosis of HIV or later stages of syphilis. It increases the STD Diagnostics Market during the forecast period. Urine samples. Some STIs can be confirmed with a urine sample. Fluid samples. If you have open genital sores, your doctor may test fluid and samples from the sores to diagnose the type of infection.

 

 

STD Diagnostics Market Regional Insights

 

The North American market accounts for the largest revenue share in the global STD Diagnostics Market.  POC tests do not identify all STDs and many of these methods don’t follow the standard regulatory norms. The United States is expected to be the largest STD Diagnostics Market in the North American region due to the presence of a large number of diagnostic companies and greater disease awareness. In May 2022, a report published by the Centers for Disease Control and Prevention titled Sexually Transmitted Disease Surveillance, 2022 stated that STDs remain a significant public health concern in the country.

 

 

 

STD Diagnostics Market Key Players

• Abbott Laboratories
• MedMira Inc
• Qaigen Inc
• Cepheid
• F. Hoffmann
• La Roche
• Diasorin S.p.A
• bioMeriuex
• Hologic
• Bio-Rad Laboratories